Lipocine Revenue, Profits - LPCN Quarterly Income Statement

Add to My Stocks
$1.52 $0.05 (3.18%) LPCN stock closing price Sep 20, 2018 (Closing)

Financial analysis of Lipocine involves more than just checking the Lipocine stock price, by looking at the financial statements of the company in detail. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from - to - and how operating and non operating activities have impacted the LPCN stock. The operating expenses as shown in the Lipocine profit and loss statement for 2018 Q2 total to $3.16M. This line item shows that the operating expenses has increased compared with last year. Also check: Lipocine assets and Lipocine free cash flow.

View and download details of revenue and profits for Lipocine for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Lipocine Revenues or Net Sales
Cost Of Goods Sold (COGS)----------
Lipocine Gross Profit
Research & Development Expense1.48M1.37M1.78M2.04M4.1M3.08M1.34M1.5M2.56M2.67M
Selling General & Admin Expense1.68M1.68M3.65M2.71M2.03M1.82M1.71M1.77M3.24M4.39M
Income Before Depreciation Depletion Amortization-3.16M-2.63M-5.41M-4.76M-6.14M-4.9M-3.02M-3.28M-5.81M-7.07M
Depreciation Depletion Amortization----------
Non Operating Income----------
Interest Expense----------
Lipocine Pretax Income
Provision for Income Taxes----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-3.26M-2.72M-5.33M-4.7M-6.09M-4.86M-2.97M-3.24M-5.76M-7.01M
Extraordinary Items & Discontinued Operations----------
Lipocine Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS21.27M21.27M21.28M20.89M19.37M18.71M18.29M18.25M18.25M18.25M
Average Shares used to compute Basic EPS21.27M21.27M21.28M20.89M19.37M18.71M18.29M18.25M18.25M18.25M
Income Before Nonrecurring Items-3.26M-2.72M-5.33M-4.7M-6.09M-4.86M-2.97M-2.85M-5.76M-7.01M
Income from Nonrecurring Items--------0.39M--
Lipocine Earnings Per Share Basic Net
Lipocine Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.15-0.13-0.25-0.22-0.31-0.26-0.16-0.16-0.32-0.38
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on Lipocine stock analysis. It helps to look at the following income statement items:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Lipocine revenue chart, implies that the company is growing. It has not been the case with Lipocine. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-3.26M for LPCN stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the LPCN income statement, one can check the Lipocine historical stock prices to check how the price has moved with time.

Lipocine Income Statement - Key Financial Ratios